Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps3-24-07 | Thyroid Eye Disease | ETA2023

Incidence and risk factors for graves’ orbitopathy in patients who underwent anti-inframmatory and immunosuppressive treatment during medical treatment for graves’ disease

Watanabe Natsuko , Noh Jaeduk , Kozaki Ai , Suzuki Nami , Yoshihara Ai , Matsumoto Masako , Fukushita Miho , Imal Hideyuki , Hiruma Shigenori , Inoue Tosyu , Sugino Kiminori , Ito Koichi

Objective: Appropriate administration of anti-inflammatory and immunosuppressive treatment (AIIST) is still important for patients with GravesÂ’ orbitopathy (GO). This study aimed to clarify the incidence of and risk factors for GO treated with AIIST, among newly diagnosed GravesÂ’ disease (GD) patients in Japan.Methods: A total of 1558 GD patients who were newly diagnosed at Ito Hospital during the year 2011 were investigated. AIIST included loc...